RT Generic
T1 Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
A1 Robles-Diaz, Mercedes
A1 Nezic, Lana
A1 Vujic-Aleksic, Vesna
A1 Bjornsson, Einar S.
K1 ursodeoxycholic acid
K1 drug-induced liver injury
K1 hepatotoxicity
K1 treatment
K1 prevention
K1 Bile-duct syndrome
K1 Acg clinical guideline
K1 Intrahepatic cholestasis
K1 Hepatotoxicity
K1 Management
K1 Diagnosis
K1 Methotrexate
K1 Steroids
K1 Therapy
K1 Failure
AB Introduction: Treatment is generally not available for drug-induced liver injury (DILI) patients except in some specific circumstances. The management of DILI is based on the withdrawal of the responsible drug and monitoring the patients and only a few patients need to be referred to a transplant center. Some studies on the role of ursodeoxycholic acid (UDCA) in DILI have been published. The aim of this study was to perform a systematic review of the role of UDCA in the treatment and prevention of DILI.Methods: A search was undertaken in PubMed, with the key words ursodeoxycholic acid, drug-induced liver injury and hepatotoxicity following the PRISMA guidelines.Results: A total of 33 publications were identified: 25 case reports and 8 case series. In 18 of the 25 cases reports (22 patients), authors reported improvement of liver injury associated with UDCA therapy whereas 7 case reports did not show clinical or biochemical improvement after UDCA treatment. There were 4 studies evaluating the role of UDCA in the treatment of DILI, three prospective (one being a clinical trial) and one retrospective studies. Three studies observed liver profile improvements associated with UDCA. In addition, four studies evaluated UDCA in the prevention of DILI: one pilot study, two randomized clinical trials (RCT) and one retrospective study. Three of these studies observed a lower percentage of patients with an increase in transaminases in the groups that used UDCA for DILI prevention.Conclusion: According to available data UDCA seems to have some benefits in the treatment and prevention of DILI. However, the design of the published studies does not allow a firm conclusion to be drawn on the efficacy of UDCA in DILI. A well designed RCT to evaluate the role of UDCA in DILI is needed.
PB Frontiers media sa
YR 2021
FD 2021-10-27
LK https://hdl.handle.net/10668/26972
UL https://hdl.handle.net/10668/26972
LA en
DS RISalud
RD Apr 14, 2025